CASEBIA THERAPEUTICS LTD LIABILITY PARTNERSHIP has a total of 15 patent applications. It increased the IP activity by 33.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are PREVAIL THERAPEUTICS INC, CRISPR THERAPEUTICS AG and CELL GENESYS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | United States | 2 | |
#3 | China | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Animal care | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Stankovich Basha | 4 |
#2 | Vo Karen | 4 |
#3 | Brooks Alan | 4 |
#4 | Coco Wayne | 3 |
#5 | Schmidt Moritz | 3 |
#6 | Cohnen Andre | 3 |
#7 | Pitzler Christian | 3 |
#8 | Klein Lawrence | 3 |
#9 | Tebbe Jan | 3 |
#10 | Bouchon Axel | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020092611A1 | Compositions and methods for nhej-mediated genome editing | |
WO2020081843A1 | Compositions and methods for delivering transgenes | |
WO2019210281A1 | Methods and compositions of cytotoxic t cell depletion | |
WO2019204668A1 | Compositions and methods for knockdown of apo(a) by gene editing for treatment of cardiovascular disease | |
US2019247517A1 | Compositions and methods for gene editing for hemophilia a | |
EP3516058A1 | Compositions and methods for gene editing |